IRSA (NYSE: IRS) sets Feb 17–25, 2026 window for warrant exercise
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
IRSA Inversiones y Representaciones has opened the penultimate exercise period for its share warrants before their maturity in May 2026. The current exercise window runs from February 17 to February 25, 2026, although custodians and intermediaries may apply earlier internal cut-off dates.
Each warrant entitles its holder to receive 1.6367 common shares with a par value of ARS 10, at an exercise price of USD 0.2641 per share. From this window onward, holders may also use a newly available “Net Exercise with Par Value Contribution” cashless alternative, approved at the October 30, 2025 shareholders’ meeting, paying only the par value per share and, if applicable, a USD 0.05 per GDS issuance fee when converting common shares into GDS.
Positive
- None.
Negative
- None.
FAQ
What did IRSA (IRS) announce regarding its warrants in February 2026?
IRSA announced that the penultimate exercise period for its share warrants is open from February 17 to February 25, 2026. This allows warrant holders to convert warrants into common shares before the instruments mature in May 2026, under the terms previously established.
What is the exercise period for IRSA (IRS) warrants in 2026?
The current IRSA warrant exercise window runs from February 17 to February 25, 2026. The company notes that Caja de Valores and intermediaries may set earlier internal deadlines for receiving exercise instructions, so holders must follow timing requirements set by their custodial institutions.
What is IRSA’s Net Exercise with Par Value Contribution option?
IRSA offers a “Net Exercise with Par Value Contribution” cashless alternative from this window onward. Under it, warrant holders receive shares equal to the value difference between market price and cash exercise price, paying only the ARS 10 par value per share to be issued.
When did IRSA (IRS) approve the cashless warrant exercise modality?
The cashless “Net Exercise with Par Value Contribution” modality was approved at IRSA’s shareholders’ meeting held on October 30, 2025. The February 2026 window is the first one where holders can choose this alternative instead of a traditional full cash exercise method.